{"id":"W4224091336","doi":"10.3390/curroncol29040222","title":"Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective","year":2022,"lang":"en","type":"review","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of British Columbia; University of Alberta; Fluidigm (Canada); Memorial University of Newfoundland; McGill University; Jewish General Hospital","funders":"AstraZeneca Canada","keywords":"Medicine; Pertuzumab; Trastuzumab; Context (archaeology); Oncology; Taxane; Trastuzumab emtansine; Capecitabine; Metastatic breast cancer; Internal medicine; Clinical trial; Breast cancer; Regimen; Intensive care medicine; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001128033,0.0007603575,0.001153631,0.003324469,0.0005270035,0.001251758,0.0009382442,0.001240794,0.005360954],"category_scores_gemma":[0.001288977,0.0002131315,0.0007082671,0.003632383,0.0006303249,0.001239453,0.0006752541,0.002513808,0.001586917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00414488,"about_ca_system_score_gemma":0.009215076,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06032084,"about_ca_topic_score_gemma":0.1613591,"domain_scores_codex":[0.999624,0.00005547902,0.00003754711,0.00003420539,0.0001935662,0.00005520379],"domain_scores_gemma":[0.9990684,0.0002423051,0.00006939098,0.00001362854,0.0005159606,0.00009029755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009131439,0.00005251561,0.0001443499,0.02290842,0.00009842069,0.0001826318,0.0001155144,0.0003463566,0.001122164,0.00669403,0.09683799,0.8714063],"study_design_scores_gemma":[0.00001443983,0.00003460133,0.0004343111,0.005495975,0.00007980805,0.0003034847,0.00004981275,0.00004078899,0.00009891721,0.0008115671,0.9926262,0.00001012197],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003773979,0.997533,0.00004486745,0.0009497646,0.0002912052,0.000003637608,0.00001603734,0.000004463619,0.001119352],"genre_scores_gemma":[0.0002466731,0.9986762,0.0001065375,0.0003720143,0.0001100552,0.000002090493,0.00001530325,9.770322e-7,0.000470032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9396791,"threshold_uncertainty_score":0.1199395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3007222558840129,"score_gpt":0.5542062625307176,"score_spread":0.2534840066467047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}